or Try an Advanced Search...

    Status Epilepticus Stocks List

    Symbol Grade Name % Change
    SAGE F Sage Therapeutics, Inc. -0.49
    SPRC F SciSparc Ltd. -5.89
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Adjunctive Therapy Alzheimer's Disease Amyloidosis Anticonvulsants Antidepressants Autism Spectrum Disorder Biology Biopharmaceutical Central Nervous System Disorders Clinical Development Dementia Drug Development Drugs Epilepsy Gabaa Receptor Positive Allosteric Modulators Nervous System Disorders Neuroscience Neurosteroids Obstructive Sleep Apnea Pain

    Related ETFs - A few ETFs which own one or more of the above listed Status Epilepticus stocks.

    Symbol Grade Name Weight
    PSIL B AdvisorShares Psychedelics ETF 5.24
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 1.8
    BBP A BioShares Biotechnology Products Fund 1.01
    QQQS A Invesco NASDAQ Future Gen 200 ETF 0.49
    BIS C ProShares UltraShort Nasdaq Biotechnology 0.48
    View all Status Epilepticus ETFs...
    Compare ETFs
    Compare PSIL to BIS Compare PSIL to LABD Compare QQQS to BIS

        Status Epilepticus Stocks Recent News

        Date Stock Title
        Oct 31 SAGE Sage Therapeutics price target lowered to $26 from $52 at Piper Sandler
        Oct 30 SAGE SAGE's Q3 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
        Oct 30 SAGE Biogen, Sage admit a defeat in major depression
        Oct 30 SAGE Sage Therapeutics Inc (SAGE) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
        Oct 30 SAGE Sage Therapeutics, Inc. (SAGE) Q3 2024 Earnings Call Transcript
        Oct 29 SAGE Sage Therapeutics, Inc. 2024 Q3 - Results - Earnings Call Presentation
        Oct 29 SAGE Sage stock plunges 18% post-market following business update, earnings
        Oct 29 SAGE Sage Therapeutics, Inc. (SAGE) Reports Q3 Loss, Tops Revenue Estimates
        Oct 29 SAGE Sage Therapeutics GAAP EPS of -$1.53 beats by $0.02, revenue of $11M misses by $0.12M
        Oct 29 SAGE Sage Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Pipeline and Business Updates
        Oct 28 SAGE Sage Therapeutics Q3 2024 Earnings Preview
        Related Industries: Biotechnology
        Related Stock Lists: Adjunctive Therapy Alzheimer's Disease Amyloidosis Anticonvulsants Antidepressants Autism Spectrum Disorder Biology Biopharmaceutical Central Nervous System Disorders Clinical Development Dementia Drug Development Drugs Epilepsy Gabaa Receptor Positive Allosteric Modulators Nervous System Disorders Neuroscience Neurosteroids Obstructive Sleep Apnea Pain
        Status Epilepticus

        Status epilepticus is a medical emergency in which a person has a seizure that lasts for a prolonged period of time or multiple seizures occur in quick succession without the person regaining consciousness in between. It is a life-threatening condition that requires immediate medical attention.

        Browse All Tags